1.
Pier Luigi Zinzani, Simonetta Viviani, Antonella Anastasia, Umberto Vitolo, Stefano Luminari, Francesco Zaja, Paolo Corradini, Michele Spina, Ercole Brusamolino, Alessandro M. Gianni, Armando Santoro, Barbara Botto, Enrico Derenzini, Cinzia Pellegrini, Lisa Argnani. Brentuximab vedotin in relapsed/refractory Hodgkin’s lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials. haematol [Internet]. 2013Jul.31 [cited 2024Jul.25];98(8):1232-6. Available from: https://haematologica.org/article/view/6748